Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Using Proteomics to Advance Drug Development – Translating Proteomics Episode 14

Key Takeaway: In the latest episode of Translating Proteomics, Nautilus Biotechnology co-hosts discuss the application of proteomics in drug development. Key topics include the role of proteomics in pre-clinical models, patient selection, and the importance of choosing appropriate endpoints in clinical trials. The episode emphasizes how proteomics can improve the efficiency and effectiveness of clinical research.
Price reaction · baseline $1.82 (2025-01-08 close) · clean, no other NAUT news in the window
day 0 close · peak
-3.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Proteomics is advancing drug development significantly.
  • The episode provides valuable insights for clinical researchers.
  • Focus on patient selection enhances clinical trial outcomes.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Applications of Proteomics
Nautilus Biotechnology
January 9, 2025
On this episode of Translating Proteomics, co-hosts Parag Mallick and Andreas Huhmer of Nautilus Biotechnology discuss how clinical researchers can leverage proteomics for drug development. Some of the themes covered in this episode include:
• Proteomics and pre-clinical models
• How proteomics can drive patient selection
• Choosing the right end points in clinical trials
This post serves as a great companion to Translating Proteomics Episode 8 – Expanding the Druggable Universe with Proteomics .
Find this episode on Apple Podcasts , Spotify , or YouTube .
Browse all episodes of Translating Proteomics.

Chapters

00:00 – 01:06 – Introduction 01:06 – 06:51 – Proteomics in pre-clinical studies 06:51 – 11:40 – The importance of choosing the right model for preclinical work 11:40 – 17:10 – How proteomics is used in Phase I/II clinical trials 17:10 – 19:29 – Proteomics tools in patient selection 19:29 – 24:33 – Useful information that we get from proteomics that we can’t get from genomics or transcriptomics 24:33 – 28:14 – Proteomics in Phase III clinical trials and picking the best indications of drug efficacy 28:14 – 29:19 – Understanding why clinical trials fail 29:19 – End – Outro

Resources

• The National Cancer Institute’s webpage covering how clinical trials work
• Preprint on the miBrain model – An example of a new in vitro brain model
• Wasko et al., 2024 – Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
• Geary et al., 2021 – Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials
• The NCI-MATCH trail: Lessons for precision oncology – Report on a large-scale trial using genomic biomarkers to match cancer patients to treatments
• Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer – Study using proteomics to understand mechanisms of resistance to a cancer drug
Find this episode on Apple Podcasts , Spotify , or YouTube .
Browse all episodes of Translating Proteomics.
Read our preprint to explore novel proteoform data and its potential in drug development.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
White paper series: The proteomics revolution
This post contains white papers describing how developments in proteomics - led by the Nautilus platform - will improve healthcare.
Read more
Targeting healthcare disparities through the proteomics revolution (Part 1)
Learn how biases have led to inequities in healthcare and how researchers can rectify those inequities with better data.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is the focus of Translating Proteomics Episode 14?

The episode discusses the application of proteomics in drug development.

How does proteomics aid in patient selection?

Proteomics helps identify suitable patients for clinical trials, enhancing outcomes.

What are the key themes covered in the episode?

Key themes include proteomics in pre-clinical models and endpoint selection.

Where can I listen to this episode?

You can find it on Apple Podcasts, Spotify, or YouTube.

Last updated: Jan 9, 2025